The K1 protein of kaposi's sarcoma-associated herpesvirus augments viral lytic replication

Journal of Virology

Volumn 90, Issue 17, 2016, Pages 7657-7666

  Zhang, Zhigang ^a   Chen, Wuguo ^a   Sanders, Marcia K ^a   Brulois, Kevin F ^a   Dittmer, Dirk P ^a   Damania, Blossom ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K1 PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; VIRAL PROTEIN; K1 PROTEIN, HUMAN HERPESVIRUS 8; STOP CODON;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; HUMAN HERPESVIRUS 8; K1 GENE; LIFE CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REACTIVATION; VIRUS REPLICATION; CELL LINE; GENE DELETION; GENE REPRESSION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; STOP CODON;

CELL LINE; CODON, NONSENSE; GENE DELETION; HERPESVIRUS 8, HUMAN; HUMANS; SUPPRESSION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84983488611     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03102-15     Document Type: Article

References (34)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi .org/10.1126/science.7997879.
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191. http://dx .doi.org/10.1056/NEJM199505043321802.
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
4. Wen KW, Damania B. 2010. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1. Oncogene 29:3532-3544. http://dx.doi.org/10.1038/onc.2010.124.
5. Grundhoff A, Ganem D. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113:124-136. http://dx.doi.org/10.1172/JCI200417803.
6. Dillon PJ, Gregory SM, Tamburro K, Sanders MK, Johnson GL, Raab-Traub N, Dittmer DP, Damania B. 2013. Tousled-like kinases modulate reactivation of gammaherpesviruses from latency. Cell Host Microbe 13:204-214. http://dx.doi.org/10.1016/j.chom.2012.12.005.
7. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. 2009. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A 106:11725-11730. http://dx.doi.org/10.1073/pnas.0905316106.
8. Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G. 2000. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 74:6207-6212. http://dx.doi .org/10.1128/JVI.74.13.6207-6212.2000.
9. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73:9348-9361.
10. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2:342-346. http://dx.doi.org /10.1038/nm0396-342.
11. Cheng F, Weidner-Glunde M, Varjosalo M, Rainio EM, Lehtonen A, Schulz TF, Koskinen PJ, Taipale J, Ojala PM. 2009. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latencyassociated nuclear antigen LANA. PLoS Pathog 5:e1000324. http://dx.doi .org/10.1371/journal.ppat.1000324.
12. Yu F, Harada JN, Brown HJ, Deng H, Song MJ, Wu TT, Kato-Stankiewicz J, Nelson CG, Vieira J, Tamanoi F, Chanda SK, Sun R. 2007. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog 3:e44. http://dx.doi.org/10.1371/journal.ppat.0030044.
13. Lagunoff M, Ganem D. 1997. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236:147-154. http://dx.doi.org/10.1006/viro.1997.8713.
14. Chandriani S, Ganem D. 2010. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 84:5565-5573. http://dx.doi.org/10.1128/JVI.02723-09.
15. Bowser BS, DeWire SM, Damania B. 2002. Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol 76:12574-12583. http://dx.doi.org/10.1128/JVI.76.24.12574-12583.2002.
16. Lee BS, Connole M, Tang Z, Harris NL, Jung JU. 2003. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol 77:8072-8086. http://dx.doi.org/10.1128/JVI.77.14.8072-8086.2003.
17. Samaniego F, Pati S, Karp JE, Prakash O, Bose D. 2001. Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr 2001:15-23.
18. Tomlinson CC, Damania B. 2004. The K1 protein of Kaposi's sarcomaassociated herpesvirus activates the Akt signaling pathway. J Virol 78:1918-1927. http://dx.doi.org/10.1128/JVI.78.4.1918-1927.2004.
19. Lagunoff M, Majeti R, Weiss A, Ganem D. 1999. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 96:5704-5709. http://dx.doi.org/10.1073/pnas.96.10.5704.
20. Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F. 2007. K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood 109:2174-2182. http://dx .doi.org/10.1182/blood-2006-02-003178.
21. Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M, Jung JU. 1998. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 18:5219-5228. http://dx.doi.org/10.1128/MCB.18.9.5219.
22. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B. 2006. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66:3658-3666. http://dx.doi .org/10.1158/0008-5472.CAN-05-3680.
23. Bhatt AP, Damania B. 2012. AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. Front Immunol 3:401. http://dx.doi.org/10.3389/fimmu.2012.00401.
24. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS, Damania B. 2004. The Kaposi's sarcoma-associated herpesvirus (KSHV/ HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64:2774-2781. http://dx.doi.org/10.1158/0008-5472.CAN-03-3653.
25. Tomlinson CC, Damania B. 2008. Critical role for endocytosis in the regulation of signaling by the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol 82:6514-6523. http://dx.doi.org/10.1128/JVI.02637-07.
26. Lagunoff M, Lukac DM, Ganem D. 2001. Immunoreceptor tyrosinebased activation motif-dependent signaling by Kaposi's sarcomaassociated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75:5891-5898. http://dx.doi.org/10.1128/JVI.75.13.5891-5898.2001.
27. Lee BS, Paulose-Murphy M, Chung YH, Connlole M, Zeichner S, Jung JU. 2002. Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J Virol 76:12185-12199. http://dx.doi.org/10.1128/JVI.76.23.12185-12199.2002.
28. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
29. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. http://dx.doi.org/10.1016/j.jviromet.2011.03.012.
30. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, Lackner A, Desrosiers RC, Jung JU. 1998. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 4:435-440. http://dx.doi.org/10.1038/nm0498-435.
31. Kedes DH, Ganem D. 1997. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99:2082-2086.
32. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340:1063-1070.
33. Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B, Gudza I, Fitzpatrick L, Schooley RT. 2000. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS 14:2109-2116. http://dx.doi.org/10.1097/00002030-200009290-00006.
34. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, Miller RF, Weller IVD. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802. http://dx.doi.org /10.1016/S0140-6736(95)91619-9.